Enforcing IP Rights in Nanotechnology: Evidentiary Challenges in Proving Infringement at the Atomic Scale
DOI:
https://doi.org/10.70445/gjus.3.1.2026.28-48Keywords:
Nanotechnology, Intellectual property rights, Patent Infringement, Nanoscale Evidence, Scientific Evidence, Patent ProtectionAbstract
IP protection poses a serious challenge in nanotechnology as patented inventions in the area are frequently atomic and molecular level structures and processes. This review explores the problems in establishing evidence of infringement in patent litigation in nanotechnology. It explores issues of nanoscale measurements, scientific testing, and access to evidence, expert testimony, confidentiality and interpreting specialist technical information. The review also includes the effect of microscopy and spectroscopy and other analytical techniques on the determination of infringement. It highlights the importance of scientific certainty, technical clarity of patent claims, experts and sound legal processes for the proper protection of innovations in nanotechnology.
References
[1]. Siri JG, Fernando CA, De Silva SN. Nanotechnology and protection of intellectual property: emerging trends. Recent Patents on Nanotechnology. 2020 Dec 1;14(4):307-27.
[2]. Bader MA, Gassmann O, Thompson MJ. Patent Management in New Technology Environments. InPatent Management: Protecting Intellectual Property and Innovation 2026 Jun 2 (pp. 205-255). Cham: Springer Nature Switzerland.
[3]. Vazhathodi MF. Nanomedicines in Patent Law: Innovation in Comparative Context. Taylor & Francis; 2026 Jul 17.
[4]. Singh H, baseer Khan A, Verma H, Tiwari V, Chaudhary S. 6 PATENT STRATEGIES AND INTELLECTUAL PROPERTY MANAGEMENT IN NANOTECHNOLOGY-BASED DRUG DELIVERY. Applications And Emerging Trends In Pharmaceutical Nanotechnology. 2026 Aug 6.
[5]. Costello-Caulkins M. Nanotechnology patent law: A case study of United States and European patent applications. Santa Clara High Tech. LJ. 2021;37:337.
[6]. Fehlan KE. Does Size Matter? Nanoscale Particle Size as an Indicator of Inherency in Nanopharmaceutical Patent Validity. Ga. St. UL Rev.. 2021;38:1057.
[7]. Yang T, Duncan TV. Challenges and potential solutions for nanosensors intended for use with foods. Nature nanotechnology. 2021 Mar;16(3):251-65.
[8]. Costello-Caulkins M. Nanotechnology patent law: A case study of United States and European patent applications. Santa Clara High Tech. LJ. 2021;37:337.
[9]. Ferrill ED, Rajan K. 3D bioprinting, nanotechnology, and intellectual property. In3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine 2022 Jan 1 (pp. 505-522). Academic Press.
[10]. Pathan RK. The Intellectual Property Conundrum: The Legal Implications of Nanotechnology and Sustainable Energy. J. Intell. Prot. Stud.. 2025;9:25.
[11]. Dhingra G, Sharma N. Strategic Management of Nanotechnology Innovation: Bridging Scientific Discovery and Commercial Value Across Industries. Int. J. Sci. R. Tech. 2026;3(2):2.
[12]. Nandekar U, Rautdesai R. Nanotechnology Patent Applications and Section 3 (d) of Indian Patents Act, 1970: An Empirical Research. Journal of Intellectual Property Rights (JIPR). 2023 Sep 19;28(5):392-401.
[13]. Wang AP, Hou CE, Hung SW. Exploration of the evolution of nanotechnology from a patent co-classification perspective. Nanotechnology Reviews. 2018 Jun 27;7(3):233-45.
[14]. Stretz HA, Kiss A, Mealio KN, Ayeni OO. Regulatory and environmental issues of nanotechnology safety. InNanotechnology Safety 2025 Jan 1 (pp. 59-76). Elsevier.
[15]. Laure HR. Nanotechnology Patent Procurement and Litigation in Europe. InNanotechnology Commercialization for Managers and Scientists 2019 Jan 23 (pp. 77-102). Pan Stanford.
[16]. Rahman Z, Charoo NA, Akhter S, Beg S, Reddy IK, Khan MA. Nanotechnology-based drug products: Science and regulatory considerations. InNanoscale fabrication, optimization, scale-up and biological aspects of pharmaceutical nanotechnology 2018 Jan 1 (pp. 619-655). William Andrew Publishing.
[17]. Varghese L. Recent Patents and Commercial Trends in Oncology Nano. Targeted Nanomedicine in Cancer Therapy: Bridging Oncology and Nanoscience. 2025 Oct 3:149.
[18]. Geipele S, Pudzis E, Uzulens J, Geipele I, Zeltins N. The Development of Nanotechnologies and Advanced Materials Industry in Science and Entrepreneurship: Legal Indicators. A Case Study of Latvia (Part Four). Latvian Journal of Physics and Technical Sciences. 2018 Aug 1;55(4):44-56.
[19]. dos Santos Fonseca LM, Machado BA, Oliveira FO, de Jesus Santos JR, da Silva JW, Hodel KV, Rosatti BG, Pinto CD, Soares MB. An overview on recent patents and technologies on nanoparticles for nucleic acid delivery. Expert Opinion on Therapeutic Patents. 2024 Mar 3;34(3):171-86.
[20]. Foladori G, Belmont ER, Arteaga Figueroa ER, Appelbaum R, Záyago Lau E. Patents and nanotechnology innovation in Mexico. Recent Patents on Nanotechnology. 2018 Dec 1;12(3):243-56.
[21]. Gassmann O, Bader MA, Thompson MJ. Patent Management in New Technology Environments. InPatent Management: Protecting Intellectual Property and Innovation 2020 Nov 29 (pp. 193-239). Cham: Springer International Publishing.
[22]. Vargas R, Martos-Kikut F, Martinez-Martinez N, Lara-Guerrero E, Lizano-Barrantes C, Pacheco-Molina JA, Romero-Obon M, Rouaz-El-Hajoui K, García-Montoya E, Pérez-Lozano P, Suñe C. From nanoscale to clinic: The growing impact of nanotechnology in translational drug delivery. ADMET and DMPK. 2026 Mar 6;14.
[23]. Yadav KS, Mandaliya VB. Nano-fertilizer for climate-smart agriculture: A comprehensive patent analysis for sustainable soil management practices. InContemporary Suitability of Nanobionics in Agriculture: Nanotechnology in Horticultural Crops 2025 Apr 24 (pp. 195-213). Cham: Springer Nature Switzerland.
[24]. Wadekar R, Mandal SC, Patil K. Intellectual property rights, naturally derived bioactive compounds, and resource conservation. InRole of Herbal Medicines: Management of Lifestyle Diseases 2024 Feb 27 (pp. 559-571). Singapore: Springer Nature Singapore.
[25]. Mishra PK, Giagli K, Tsalagkas D, Mishra H, Talegaonkar S, Gryc V, Wimmer R. Changing face of wood science in modern era: Contribution of nanotechnology. Recent Patents on Nanotechnology. 2018 Apr 1;12(1):13-21.
[26]. Van Calster G. 11 From big statements to anecdotal and incremental regulation: Nanotechnology and the law in the EU. Ethics in Nanotechnology: Social Sciences and Philosophical Aspects. 2021 Sep 7:281.
[27]. Bawa R. Drug delivery at the nanoscale: a guide for scientists, physicians and lawyers. InThe road from nanomedicine to precision medicine 2019 Dec 9 (pp. 1-134). Jenny Stanford Publishing.
[28]. Bhatt PV, Pandey G, Tharmavaram M, Rawtani D, Mustansar Hussain C. Nanotechnology and taggant technology in forensic science. Technology in forensic science: Sampling, analysis, data and regulations. 2020 Oct 19:279-301.
[29]. Silva MD, Saraiva Hodel KV, Fonseca LD, da Hora HS, Murari TB, Pinto CD, Machado BA. Patent landscape of nanotechnology–based nucleic acid delivery systems for breast cancer therapies. Frontiers in Oncology. 2026 Jan 14;15:1702392.
[30]. Khopade AJ, Shah M. Challenges for commercial translation of nanomedicines: from lab scale to production scale. InCommercial scale production of nanomedicines 2025 Aug 21 (pp. 1-40). CRC Press.
[31]. Ahmad MI, HPS AK. Challenges and Prospective in Bio-based Nanotechnology for Environmental and Energy Applications. InEnvironmental and Energy Technology: Micro to Nano Bio-Based Materials 2026 Jan 2 (pp. 365-399). Cham: Springer Nature Switzerland.
[32]. Nordberg A. Patentability of human enhancement: from ethical dilemmas to legal (un) certainty. InIntellectual Property Perspectives on the Regulation of New Technologies 2018 Nov 30 (pp. 54-92). Edward Elgar Publishing.
[33]. Sattler KD, editor. 21st Century Nanoscience–A Handbook: Public Policy, Education, and Global Trends (Volume Ten). CRC Press; 2020 Nov 13.
[34]. Mishra H. Nanobiostimulants and precision agriculture: a data-driven approach to farming and market dynamics. InNanobiostimulants: Emerging strategies for agricultural sustainability 2024 Nov 12 (pp. 365-398). Cham: Springer Nature Switzerland.
[35]. Amentae TK, Song W. Exploring Ethiopia's intellectual property rights system: prospects and grey areas for agro-food chain sector innovations. International Journal of Intellectual Property Management. 2026;16(2):197-227.
[36]. Raghuwanshi N, Isad V, Shanmathi RK, Kale C. Bridging the gap: regulatory pathway and clinical translation of nanomaterials in medicines. InSmart Nanomaterials in Biomedical Applications: Properties and Functional Behaviors 2025 Nov 18 (pp. 305-337). Singapore: Springer Nature Singapore.
[37]. Hull MS, Bowman DM. Nanotechnology environmental health and safety: risks, regulation, and management. William Andrew Publishing; 2018 Aug 17.
[38]. Starling-Windhof A, Srinivasan A, Tomeo T, Clark AM, Mattei P. Trends in the intellectual property (IP) landscape of drug delivery systems: 30 years of growth and evolution. InNanopharmaceuticals 2020 Jan 1 (pp. 201-230). Elsevier.
[39]. Marx M, Fuegi A. Reliance on science: Worldwide front‐page patent citations to scientific articles. Strategic Management Journal. 2020 Sep;41(9):1572-94.
[40]. Islam N, Gyoshev SB, Amona D. Internal Dynamics and Innovation Performance of Collaborative Partnerships in Nanotechnology R&D Organisations. Available at SSRN 5261123.
[41]. Yadav KS, Mandaliya VB. Agriculture: A Comprehensive Patent Analysis for Sustainable Soil Management. Contemporary Suitability of Nanobionics in Agriculture: Nanotechnology in Horticultural Crops. 2025 Apr 23:195.
[42]. Joseph TM, Kar Mahapatra D, Esmaeili A, Piszczyk Ł, Hasanin MS, Kattali M, Haponiuk J, Thomas S. Nanoparticles: taking a unique position in medicine. Nanomaterials. 2023 Jan 31;13(3):574.
[43]. Quazi HA. Commercializing nanotechnology: a roadmap to taking Nanoproducts from laboratory to market. CRC Press; 2020 Nov 15.
[44]. Saharan S, Hoque S, Neware P, Ravichandiran V, Gaikwad V. Current Clinical, Regulatory, and Patent Aspects of PEGylated Nanoproducts. InPEGylated Nanocarriers in Medicine and Pharmacy 2025 Mar 1 (pp. 495-554). Singapore: Springer Nature Singapore.
[45]. Mody N, Jain A. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers. InTumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers 2025 Jan 1 (pp. 409-425). Academic Press.
[46]. Banik BK, Singh P, Pandey G, editors. Exploring Nanotechnology for a Sustainable Economy. CRC Press; 2025 Dec 10.
[47]. Mani S. India’s patenting record since TRIPS compliance of her patent regime. Asian Journal of Technology Innovation. 2021 Sep 2;29(3):427-54.
[48]. Ren J, Zhang X, Si X, Kong X, Cong J, Wang P, Li X, Zhang Q, Yao P, Li M, Cai Y. The Race of mRNA therapy: Evidence from Patent Landscape.
[49]. Aithal PS. Industry Analysis of the Nanotechnology Industry in India. Poornaprajna International Journal of Emerging Technologies (PIJET). 2026 Mar 12;3(1):32-78.
[50]. Opderbeck DW. Artificial intelligence in pharmaceuticals, biologics, and medical devices: present and future regulatory models. Fordham L. Rev.. 2019;88:553.
[51]. Renn O, Roco MC. Nanotechnology and the need for risk governance. InEmerging technologies 2020 Jul 26 (pp. 321-359). Routledge.
[52]. Kreiling L, Robinson DK, Winickoff D. Collaborative platforms for innovation in advanced materials. OECD Science, Technology and Industry Policy Papers. 2020 Dec 14.
[53]. Moradi MA, Hedayati MR. Rethinking Institutional Enablers of Entrepreneurial Ecosystem: A Conceptual Framework for Nanotechnology Development. Available at SSRN 5072501.
[54]. Awasthi KK, Sankhla MS, Yadav CS, Awasthi A, editors. Nanoparticles in Fingerprinting: Advanced Methods for Development of Latent Fingerprints. CRC Press; 2025 Oct 21.
[55]. Anderson DM, Whitford A. Integrating logics in the governance of emerging technologies: the case of nanotechnology. Cambridge University Press; 2021 Mar.
[56]. Naseer B, Srivastava G, Qadri OS, Faridi SA, Islam RU, Younis K. Importance and health hazards of nanoparticles used in the food industry. Nanotechnology Reviews. 2018 Dec 1;7(6):623-41.
[57]. Asadifard R, Khaledi A, Pourasgari P, Nasri S. Asymmetric technological collaboration between startups and large companies: challenges in the Iranian nanotechnology sector. Innovation: The European Journal of Social Science Research. 2025 Oct 2;38(4):1614-47.
[58]. Amona TD. Complexities in Inter-firm R&D Collaborative Partnerships in High-Tech Industries: Innovation and Financial Performances. University of Exeter (United Kingdom); 2018.
[59]. Wu F, Tang X, Luo X, Li C, Lai X, Li D, Li H. Patent Landscape and Technological Trajectory of Drug Delivery Systems for Overcoming Drug Resistance in Non-small Cell Lung Cancer. Recent Patents on Anti-Cancer Drug Discovery. 2026 May 15.
[60]. Asadifard R, Khaledi A, Pourasgari P, Nasri S. Asymmetric technological collaboration between startups and large companies: challenges in the Iranian nanotechnology sector. Innovation: The European Journal of Social Science Research. 2025 Oct 2;38(4):1614-47.
